ULTRASOUND (US) ASSESSMENT OF SKIN THICKNESS IN SYSTEMIC SCLEROSIS (SSC) PATIENTS TREATED WITH IV CYCLOPHOSPHAMIDE (CYC) FOR INTERSTITIAL LUNG DISEASE (ILD): A PILOT STUDY TO ASSESS SENSITIVITY TO CHANGE

被引：0
|
作者：
Ottewell, Lesley [1 ]
Walker, Karen [1 ]
Griffiths, Bridget [1 ]
机构：
[1] Freeman Rd Hosp, Newcastle Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England
来源：
RHEUMATOLOGY | 2010年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I111 / I112
页数：2
相关论文
共 50 条
  • [1] LONG-TERM OUTCOME OF A TARGETED TREATMENT REGIMEN WITH IV CYCLOPHOSPHAMIDE (CYC) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) AND INTERSTITIAL LUNG DISEASE (ILD)
    Ottewell, Lesley
    Walker, Karen
    Griffiths, Bridget
    RHEUMATOLOGY, 2009, 48 : I76 - I76
  • [2] MYCOPHENOLATE MOPHETIL IN THE TREATMENT OF SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE (SSC-ILD) IN PATIENTS UNRESPONSIVE TO CYCLOPHOSPHAMIDE (CYC)
    Cuomo, G.
    Abignano, G.
    Iudici, M.
    Petrillo, A.
    Valentini, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S167 - S167
  • [3] Effect of intravenous pulse cyclophosphamide (CYC) on interstitial lung disease and on the extent and severity of skin involvement in systemic sclerosis (SSc)
    Sandorfi, N
    Jimenez, SA
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S637 - S637
  • [4] TREATMENT OF SKIN DISEASE IN SYSTEMIC SCLEROSIS (SSc): RESPONSE TO A TARGETED TREATMENT REGIMEN WITH IV CYCLOPHOSPHAMIDE (CYC)
    Ottewell, Lesley
    Walker, Karen
    Griffiths, Bridget
    RHEUMATOLOGY, 2009, 48 : I75 - I75
  • [5] COMPARISON OF THE EFFICACY AND SAFETY OF CYCLOPHOSPHAMIDE (SP) AND RITUXIMAB (RTM) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ananieva, L.
    Garzanova, L.
    Desinova, O.
    Ovsyannikova, O.
    Starovoytova, M.
    CHEST, 2020, 157 (06) : 373A - 373A
  • [6] Treatment of systemic sclerosis with severe interstitial lung disease (ILD) unresponsive to cyclophosphamide (CYC) with mycophenolate mofetil (MMIT).
    Mouthon, L
    Valeyre, D
    Brauner, M
    Lamberto, C
    André, MH
    Mahr, A
    Guillevin, L
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S559 - S559
  • [7] ULTRASOUND LUNG COMETS (ULC) MAY HELP THE SCREENING OF INTERSTITIAL LUNG DISEASE (ILD) IN SYSTEMIC SCLEROSIS (SSC)
    Barskova, T.
    Gargani, L.
    Picano, E.
    Guiducci, S.
    Cerinic, M. Matucci
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 188 - 188
  • [8] The Scleroderma Lung Study II (SLS II) Shows That Both Oral Cyclophosphamide (CYC) and Mycophenolate Mofitil (MMF) Are Efficacious in Treating Progressive Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc)
    Clements, Philip J.
    Tashkin, Donald
    Roth, Michael
    Khanna, Dinesh
    Furst, Daniel E.
    Tseng, Chi-hong
    Volkmann, Elizabeth R.
    Elashoff, Robert
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] Factors Associated With Progression of Interstitial Lung Disease in Patients With Systemic Sclerosis (SSc-ILD)
    Yosboot, A.
    Muangchan, C.
    Teerapuncharoen, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [10] Nailfold Capillaroscopy in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Treated with Nintedanib
    Smith, Vanessa
    Denton, Christopher
    Herrick, Ariane
    Ittrich, Carina
    Alves, Margarida
    Cutolo, Maurizio
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1241 - 1243
12345